IL220384A0 - Therapeutic combinations of theobromine and an antihistamine - Google Patents

Therapeutic combinations of theobromine and an antihistamine

Info

Publication number
IL220384A0
IL220384A0 IL220384A IL22038412A IL220384A0 IL 220384 A0 IL220384 A0 IL 220384A0 IL 220384 A IL220384 A IL 220384A IL 22038412 A IL22038412 A IL 22038412A IL 220384 A0 IL220384 A0 IL 220384A0
Authority
IL
Israel
Prior art keywords
theobromine
antihistamine
therapeutic combinations
therapeutic
combinations
Prior art date
Application number
IL220384A
Other languages
English (en)
Original Assignee
Biocopea Ltd
John Brew
Robin Mark Bannister
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd, John Brew, Robin Mark Bannister filed Critical Biocopea Ltd
Publication of IL220384A0 publication Critical patent/IL220384A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL220384A 2009-12-14 2012-06-13 Therapeutic combinations of theobromine and an antihistamine IL220384A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Publications (1)

Publication Number Publication Date
IL220384A0 true IL220384A0 (en) 2012-08-30

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220384A IL220384A0 (en) 2009-12-14 2012-06-13 Therapeutic combinations of theobromine and an antihistamine

Country Status (17)

Country Link
EP (1) EP2512472A1 (es)
JP (2) JP2013513652A (es)
CN (1) CN102802625A (es)
AU (1) AU2010332495C1 (es)
BR (1) BR112012014159A8 (es)
CA (1) CA2784215A1 (es)
CO (1) CO6541638A2 (es)
GB (1) GB0921803D0 (es)
IL (1) IL220384A0 (es)
MX (1) MX2012006624A (es)
NZ (1) NZ600267A (es)
PE (1) PE20121538A1 (es)
RU (1) RU2012129675A (es)
SG (2) SG10201408374WA (es)
UA (1) UA105827C2 (es)
WO (1) WO2011073647A1 (es)
ZA (1) ZA201204294B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
CN103263533B (zh) * 2013-05-31 2014-11-05 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂
CN104224819B (zh) * 2014-09-18 2016-08-17 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3766885D1 (en) * 1986-04-17 1991-02-07 Alza Corp Chlorpheniramine therapie.
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
JPH10316568A (ja) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003012514A (ja) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
JP2010523695A (ja) * 2007-04-11 2010-07-15 アルコン リサーチ， リミテッド アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのＴＮＦαのインヒビターおよび抗ヒスタミン薬の使用

Also Published As

Publication number Publication date
AU2010332495A1 (en) 2012-06-21
UA105827C2 (uk) 2014-06-25
BR112012014159A2 (pt) 2017-08-29
PE20121538A1 (es) 2012-12-21
EP2512472A1 (en) 2012-10-24
GB0921803D0 (en) 2010-01-27
JP2013513652A (ja) 2013-04-22
MX2012006624A (es) 2012-10-05
RU2012129675A (ru) 2014-01-27
AU2010332495C1 (en) 2016-02-11
SG10201408374WA (en) 2015-01-29
BR112012014159A8 (pt) 2017-12-26
AU2010332495B2 (en) 2015-01-22
SG181603A1 (en) 2012-07-30
ZA201204294B (en) 2013-02-27
WO2011073647A1 (en) 2011-06-23
CO6541638A2 (es) 2012-10-16
CN102802625A (zh) 2012-11-28
JP2016040280A (ja) 2016-03-24
JP6078605B2 (ja) 2017-02-08
NZ600267A (en) 2013-07-26
CA2784215A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
HK1173654A1 (zh) 治療化合物及相關的使用方法
IL215251A0 (en) Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
IL220384A0 (en) Therapeutic combinations of theobromine and an antihistamine
EP2477634A4 (en) FORMULATIONS FOR INJECTION OF NON-SEDATIVE ANTIHISTAMINE AND THEIR METHODS OF USE
HK1217903A1 (zh) 施用吡非尼酮療法的方法
IL218316A0 (en) Combination therapy with nanoparicle compositions of taxane and hedgehog inhibitors
PL2448581T3 (pl) Kompozycje terapeutyczne i odnośne sposoby ich stosowania
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
EP2429566A4 (en) CYCLINE-DEPENDENT KINASE INHIBITORS AND METHODS OF USE
SG10201405568UA (en) 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
EP2411024A4 (en) Variants of factor viii and associated methods of use
IL218212A0 (en) Therapeutic methods and compositions
HRP20130538T1 (en) Therapeutic uses of quinazolinedione derivatives
EP2393787A4 (en) CADHERINE 11 INHIBITORS AND METHOD FOR THEIR USE
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB201211237D0 (en) CDK5 inhibitors and therapeutic uses thereof
PL2442811T3 (pl) Teobromina w terapii kaszlu
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
EP2509601A4 (en) SMALL PYRIMIDINE DERIVATIVES AND METHODS OF USE
GB0819854D0 (en) Therapeutic use of zolpidem
GB0809936D0 (en) Therapeutic use of zolpidem
HK1174620A1 (zh) 吲唑基取代的二氫異噁唑並吡啶及其使用方法
GB0913300D0 (en) Therapeutic compounds and their use
TWM369662U (en) Improvement of portable ashtray
GB0903651D0 (en) Inhibitors of glyoxalase